HLA-C and cancer: To maximize reproducibility of neoepitope analyses, we advise users to (i) use the same input samples for cancer and normal samples, (ii) to align the order of pipeline steps, (iii) to use the same software version for similar steps, such as the alignment, the variant calling or the MHC-binding steps, and (iv) use similar levels of stringency for the filtering steps.